Skip to main content

Table 4 Baseline demographic and Characteristics between initiating organization and collaborating organizations

From: Multimodality management for chronic subdural hematoma in China: protocol and characteristics of an ambidirectional, nationwide, multicenter registry study

Parameters

Total (N = 2173)

Initiating organization cohort (N = 527)

Collaborating organizations cohort (N = 1646)

P value

Age, years

70.12 ± 14.53

70.08 ± 16.18

70.14 ± 13.95

0.938

Male

1762 (81.1)

405 (76.9)

1357 (82.4)

0.004

Nationalities

   

0.023

 Han

2087 (96.0)

515 (97.7)

1572 (95.5)

 

 Other

86 (4.0)

12 (2.3)

74 (4.5)

 

Main manifestation

 Headache

1262 (58.1)

298 (56.5)

964 (58.6)

0.413

 Dizziness

877 (40.4)

205 (38.9)

672 (40.8)

0.433

 Limbs powerless

1121 (51.6)

265 (50.3)

856 (52.0)

0.492

 Nausea

110 (5.1)

33 (6.3)

77 (4.7)

0.149

Type of treatment

 Conservation

557 (25.6)

299 (56.7)

258 (15.7)

< 0.001

 Burr hole

1333 (61.3)

133 (25.2)

1200 (72.9)

< 0.001

 History of trauma

1044 (48.0)

172 (32.6)

872 (53.0)

< 0.001

 Body height

167.62 ± 10.11

168.10 ± 11.25

167.43 ± 9.61

0.238

 Weight, median

65.61 ± 11.32

67.30 ± 12.39

65.00 ± 10.84

< 0.001

Occupation

   

< 0.001

 Peasantry

804 (37.0)

12 (2.3)

792 (48.1)

 

 Worker

143 (6.6)

23 (4.4)

120 (7.3)

 

 Retiree

536 (24.7)

201 (38.1)

335 (20.4)

 

 Other

690 (31.8)

291 (55.2)

399 (24.2)

 

 Patients completed 6 months follow-up

2117 (97.4)

523 (99.2)

1594 (96.8)

0.002

 Admission mRS, Median [IQR]

2 [1–3]

3 [2–4]

2 [1–3]

< 0.001

 Favorable outcome at 3 months

1931 (88.9)

478 (90.7)

1453 (88.3)

0.123

 Recurrence at 3 months

52 (2.4)

13 (2.5)

39 (2.4)

0.899